Gottlieb: Branded Industry 'Gaming' Tactics Have Shifted From Regulatory To Commercial Space
• By Michael Cipriano
Scoot Gottlieb feels that the US FDA's efforts to stop certain brand firms from gaming the system to block generics have at least shifted the playing field even if they haven't eliminated the problem.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
